Charles River Laboratories | CRL - Операционный доход





Операционный доход Изменить Дата
Agilent USD 399M 46M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 10.2M 66.1M 2026-03
Cardinal Health USD 861M 98M 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cigna USD 2.76B 204M 2026-03
Concord Medical Services Hldg CNY -144.65M 69.38M 2025-06
CVS Health USD 4.68B 2.57B 2026-03
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Elevance Health USD -5.81B 6.39B 2026-03
Humana USD 1.75B 2.56B 2026-03
Illumina USD 239M 17M 2026-03
Incyte USD 324.17M 59.7M 2026-03
Intrexon USD -60.84M 26.62M 2024-06
IQVIA Holdings USD 565M 2.11B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Lonza CHF 673M 243M 2025-06
McKesson USD 1.84B 181M 2026-03
Merck EUR 1.05B 572M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.99B 340M 2026-03
Quest Diagnostics USD 399M 13M 2026-03
Revvity USD 82.77M 63.06M 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
UnitedHealth USD 9.04B 5.78B 2026-03
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 148M 122.52M 2026-03
West Pharmaceutical Services USD 177.1M 14.6M 2026-03